Hugel Holds 'Focus Group Seminar' Introducing Products and Procedures

Medical aesthetic specialist company Hugel announced on the 31st that it successfully concluded the ‘Focus Group Seminar’ held for the first time in 2024. Hugel’s Focus Group Seminar is an academic event held regionally to share the latest academic information and trends related to beauty and plastic surgery.

Hugel held its first 'Focus Group Seminar' of 2024 on the 27th at the Mondrian Hotel in Yongsan-gu, Seoul.
[Photo by Hugel]

The seminar was held on the 27th at the Mondrian Hotel in Yongsan-gu, Seoul, under the theme ‘Let’s Pair-Play.’ With over 100 medical professionals from across the country in attendance, Hugel introduced combined procedure guidelines and related clinical cases involving its products.

Dr. Oh Min-jin of Ara Clinic explained that when combining the botulinum toxin ‘Botulax’ and the hyaluronic acid (HA) filler ‘Bylizen Skinbooster HA’ for procedures, various skin aging indicators can be improved. Dr. Park Shin-hye of Miho Clinic introduced the combination of Botulax and ‘Bylizen Skinbooster Exemit’ for hair loss and scalp regeneration. She explained that related companies are working on adding indications related to hair loss for the toxin, and clinical cases have confirmed improvements in hair count and thickness. Following this, Dr. Choi Ho-sung of Pionacle Clinic presented procedural methods for mid- and lower-face contour improvement using ‘Blue Rose Mesh’ and ‘The Chaum.’

Discussion and hands-on sessions were held by topic. Various programs were prepared where participants could share procedure videos and directly experience the textures and injection sensations of the products. Conducted in small groups, the sessions allowed for closer communication and Q&A, receiving high praise from attendees.

Dr. Jang Doo-yeol, director of Change Clinic and chairperson of the seminar, said, “This seminar is meaningful in that it presented new procedural guidelines utilizing Hugel’s diverse products,” adding, “Along with procedural methods reflecting the latest trends, various supporting data and cases were presented, which are expected to be more practically useful in actual clinical settings.”

A Hugel representative stated, “Hugel is the world’s first company to establish a medical aesthetic triad of botulinum toxin, HA filler, and sutures, striving to create the best synergy by combining various products in its portfolio,” and added, “We will continue to present in-depth and rich academic content so that the Focus Group Seminar can establish itself as a leading platform for exchange in the domestic beauty and plastic surgery fields.”

This content was produced with the assistance of AI translation services.